MDR1 gene expression in lymphocytes of patients with renal transplants

Nephron
M GötzlR Pirker

Abstract

The MDR1 gene, a multidrug resistance gene, codes for P-glycoprotein which pumps hydrophobic drugs out of the cells. Since cyclosporins also bind to P-glycoprotein and might be pumped by this transmembrane protein, we determined the expression of the MDR1 gene in the lymphocytes of 32 patients with renal transplants. MDR1 RNA expression of lymphocytes was measured by slot blot analysis and compared to the expression of drug-sensitive KB-3-1 cells and multidrug-resistant KB-8-5 cells. MDR1 RNA expression was detected in the lymphocytes of 9 (28%) patients, whereas no expression was seen in the remaining 23 patients. No association between MDR1 RNA expression and transplant function or hematological parameters was observed. However, none of the 6 patients who had transplants for more than 40 months expressed the MDR1 gene in their lymphocytes. In conclusion, expression of the MDR1 gene does occur in lymphocytes of patients with renal transplants and might reduce the immunosuppressive efficacy of cyclosporins through enhanced efflux of cyclosporins.

Citations

Sep 2, 1998·Transplantation Proceedings·E VergaraR G Del Moral
Oct 12, 1999·Journal of Clinical Pharmacology·A Lo, G J Burckart
Aug 23, 2002·Clinical Pharmacokinetics·Uwe ChristiansAlfonso Lampen
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Jill S Warrington, Leslie M Shaw
Jul 5, 2016·Biological & Pharmaceutical Bulletin·Hideyuki KushiharaTakaaki Kobayashi
Jan 19, 2006·Therapeutic Drug Monitoring·Uwe ChristiansManuel Haschke
Feb 16, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Pål FalckJan Leo Egge Reubsaet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.